FCMV
Foresite Capital Management V Portfolio holdings
AUM
$80.7M
This Quarter Return
+43.02%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
–
10 Year Return
–
AUM
$73.4M
AUM Growth
+$73.4M
(+17%)
Cap. Flow
-$10.7M
Cap. Flow
% of AUM
-14.53%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
1
Reduced
–
Closed
3
Top Buys
| 1 |
Hims & Hers Health
HIMS
|
$890K |
| 2 |
ME
23andMe Holding Co. Class A Common Stock
ME
|
$212K |
Top Sells
| 1 |
Aclaris Therapeutics
ACRS
|
$8.62M |
| 2 |
Compass Therapeutics
CMPX
|
$2.46M |
| 3 |
Pharvaris
PHVS
|
$692K |
Sector Composition
| 1 | Healthcare | 53.51% |
| 2 | Consumer Staples | 46.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Hims & Hers Health
HIMS
$9.57B
| $34.1M | 46.49% | 3,833,381 +100,000 | +3% | +$890K |
|
|
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $16.6M | 22.67% | 4,108,796 | – | – |
|
3
Disc Medicine
IRON
$2.07B
| $14.1M | 19.16% | 243,513 | – | – |
|
|
KNTE
4
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $8.36M | 11.39% | 3,525,957 | – | – |
|
|
ME
5
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $212K | 0.29% | +232,200 | New | +$212K |
|
|
6
Aclaris Therapeutics
ACRS
$209M
| – | – | -1,258,243 | Closed | -$8.62M |
|
|
7
Compass Therapeutics
CMPX
$483M
| – | – | -1,246,977 | Closed | -$2.46M |
|
|
8
Pharvaris
PHVS
$1.39B
| – | – | -33,142 | Closed | -$692K |
|